US biotech company Moderna said Monday that its coronavirus vaccine candidate was shown to provide strong protection against the deadly virus. Moderna said interim results from ongoing human trials show that its novel coronavirus vaccine candidate appears to be 94.5 per cent effective in preventing a Covid-19 infection, the deadly disease that has caused a global pandemic.

Moderna's and Pfizer's back-to-back positive announcements offer the world much-needed hope.

Unlike Pfizer vaccine, Moderna's news is more hopeful as it has higher storing temperatures and new vaccine technology.

Watch the full report.